The respiratory care devices market is expected to reach USD 34.53 billion by 2027 from USD 18.32 billion in 2020, at a CAGR of 9.3% during the forecast period of 2020 to 2027.
Respiratory care devices are used in the upper respiratory tract, trachea, bronchi, bronchioles, alveoli, pleura, and pleural cavity, and the nerves and muscles of breathing for the treatment. The prevalence of various respiratory diseases is increasing at an alarming rate. As per WHO, over 65 million people are registered to have chronic obstructive pulmonary disease (COPD), out of which about 3 million die every year. In addition to this, over 100 million people suffer from sleep-disordered breathing each year. in line with this, leading manufacturers are focusing on manufacturing innovative products. In 2017, Philips launched full face mask for respiratory diseases in the U. S. Moreover, leading players are entering into strategic collaborations, and partnerships.
Therapeutic Respiratory Devices is expected to Hold Major Market Share for Respiratory Diseases
Rapid technological advancements and growing adoption of therapeutic respiratory devices are major factor dirivng the market growth. Increasing need of emergency treatment for chronic respiratory treatment and increasing demand for nebulizer devices for treatment associated with lung diseases in children are propelling demand for therapeutic respiratory devices. Moreover, various government reimbustment plans such as Medicaid and Medicare aided by CMS for Continuous Positive Airway Pressure devices for treatment of COPD and Obstructive Sleep Apnea (OSA) is expected to fuel the market growth. Increasing demand for therapeutic respiratory devices various manufactres engaged in strategic partnership is expected to boost the market growth. For insatnce, In 2015, chart industries o acquired Thermax, is one of the leading vaporizers manufactures and deals in power vaporizer solutions.
Asia Pacific Market is expected to the Fastest Growing Market for Respiratory Care Devices
The respiratory care devices market is expected to reach USD 34.53 billion by 2027 from USD 18.32 billion in 2020, at a CAGR of 9.3% during the forecast period of 2020 to 2027.
Respiratory care devices are used in the upper respiratory tract, trachea, bronchi, bronchioles, alveoli, pleura, and pleural cavity, and the nerves and muscles of breathing for the treatment. The prevalence of various respiratory diseases is increasing at an alarming rate. As per WHO, over 65 million people are registered to have chronic obstructive pulmonary disease (COPD), out of which about 3 million die every year. In addition to this, over 100 million people suffer from sleep-disordered breathing each year. in line with this, leading manufacturers are focusing on manufacturing innovative products. In 2017, Philips launched full face mask for respiratory diseases in the U. S. Moreover, leading players are entering into strategic collaborations, and partnerships.
Therapeutic Respiratory Devices is expected to Hold Major Market Share for Respiratory Diseases
Rapid technological advancements and growing adoption of therapeutic respiratory devices are major factor dirivng the market growth. Increasing need of emergency treatment for chronic respiratory treatment and increasing demand for nebulizer devices for treatment associated with lung diseases in children are propelling demand for therapeutic respiratory devices. Moreover, various government reimbustment plans such as Medicaid and Medicare aided by CMS for Continuous Positive Airway Pressure devices for treatment of COPD and Obstructive Sleep Apnea (OSA) is expected to fuel the market growth. Increasing demand for therapeutic respiratory devices various manufactres engaged in strategic partnership is expected to boost the market growth. For insatnce, In 2015, chart industries o acquired Thermax, is one of the leading vaporizers manufactures and deals in power vaporizer solutions.
Asia Pacific Market is expected to the Fastest Growing Market for Respiratory Care Devices
Asia Pacific is housing a huge geriatric population. As per research, the greyed and pediatric population are at a higher risk of developing respiratory disease, which is further driving the market growth. In 2016, around 12 million people suffered from respiratory diseases in India, the WHO. In 2017, around 100 million people suffered from COPD in China. Besides, smoking is another reason responsible for various respiratory diseases. In India, the smoker population was around 20.6% in 2016.
The Middle East & Africa are expecting a healthy growth during the forecast period 2019–2026. This can be attributed to the poor healthcare infrastructure in Africa. However, growing urbanization, improving healthcare infrastructure, and increasing disposable income in the Middle Eastern countries such as the UAE, Saudi Arabia, and Kuwait are projected to drive the market growth. To attend to the situation, various organizations are setting up camps to spread awareness regarding respiratory diseases in the region. For instance, The Pan African Thoracic Society (PATS), a non-profit organization, is actively involved in spreading awareness about respiratory diseases.
Respiratory care devices are used in the upper respiratory tract, trachea, bronchi, bronchioles, alveoli, pleura, and pleural cavity, and the nerves and muscles of breathing for the treatment. The prevalence of various respiratory diseases is increasing at an alarming rate. As per WHO, over 65 million people are registered to have chronic obstructive pulmonary disease (COPD), out of which about 3 million die every year. In addition to this, over 100 million people suffer from sleep-disordered breathing each year. in line with this, leading manufacturers are focusing on manufacturing innovative products. In 2017, Philips launched full face mask for respiratory diseases in the U. S. Moreover, leading players are entering into strategic collaborations, and partnerships.
Therapeutic Respiratory Devices is expected to Hold Major Market Share for Respiratory Diseases
Rapid technological advancements and growing adoption of therapeutic respiratory devices are major factor dirivng the market growth. Increasing need of emergency treatment for chronic respiratory treatment and increasing demand for nebulizer devices for treatment associated with lung diseases in children are propelling demand for therapeutic respiratory devices. Moreover, various government reimbustment plans such as Medicaid and Medicare aided by CMS for Continuous Positive Airway Pressure devices for treatment of COPD and Obstructive Sleep Apnea (OSA) is expected to fuel the market growth. Increasing demand for therapeutic respiratory devices various manufactres engaged in strategic partnership is expected to boost the market growth. For insatnce, In 2015, chart industries o acquired Thermax, is one of the leading vaporizers manufactures and deals in power vaporizer solutions.
Asia Pacific Market is expected to the Fastest Growing Market for Respiratory Care Devices
The respiratory care devices market is expected to reach USD 34.53 billion by 2027 from USD 18.32 billion in 2020, at a CAGR of 9.3% during the forecast period of 2020 to 2027.
Respiratory care devices are used in the upper respiratory tract, trachea, bronchi, bronchioles, alveoli, pleura, and pleural cavity, and the nerves and muscles of breathing for the treatment. The prevalence of various respiratory diseases is increasing at an alarming rate. As per WHO, over 65 million people are registered to have chronic obstructive pulmonary disease (COPD), out of which about 3 million die every year. In addition to this, over 100 million people suffer from sleep-disordered breathing each year. in line with this, leading manufacturers are focusing on manufacturing innovative products. In 2017, Philips launched full face mask for respiratory diseases in the U. S. Moreover, leading players are entering into strategic collaborations, and partnerships.
Therapeutic Respiratory Devices is expected to Hold Major Market Share for Respiratory Diseases
Rapid technological advancements and growing adoption of therapeutic respiratory devices are major factor dirivng the market growth. Increasing need of emergency treatment for chronic respiratory treatment and increasing demand for nebulizer devices for treatment associated with lung diseases in children are propelling demand for therapeutic respiratory devices. Moreover, various government reimbustment plans such as Medicaid and Medicare aided by CMS for Continuous Positive Airway Pressure devices for treatment of COPD and Obstructive Sleep Apnea (OSA) is expected to fuel the market growth. Increasing demand for therapeutic respiratory devices various manufactres engaged in strategic partnership is expected to boost the market growth. For insatnce, In 2015, chart industries o acquired Thermax, is one of the leading vaporizers manufactures and deals in power vaporizer solutions.
Asia Pacific Market is expected to the Fastest Growing Market for Respiratory Care Devices
Asia Pacific is housing a huge geriatric population. As per research, the greyed and pediatric population are at a higher risk of developing respiratory disease, which is further driving the market growth. In 2016, around 12 million people suffered from respiratory diseases in India, the WHO. In 2017, around 100 million people suffered from COPD in China. Besides, smoking is another reason responsible for various respiratory diseases. In India, the smoker population was around 20.6% in 2016.
The Middle East & Africa are expecting a healthy growth during the forecast period 2019–2026. This can be attributed to the poor healthcare infrastructure in Africa. However, growing urbanization, improving healthcare infrastructure, and increasing disposable income in the Middle Eastern countries such as the UAE, Saudi Arabia, and Kuwait are projected to drive the market growth. To attend to the situation, various organizations are setting up camps to spread awareness regarding respiratory diseases in the region. For instance, The Pan African Thoracic Society (PATS), a non-profit organization, is actively involved in spreading awareness about respiratory diseases.
- Aerospace and Defense
- Agriculture
- Automotive and Transportation
- Business and Finance
- Chemical and Materials
- Consumer Goods and Retails
- Electronics and Semiconductor
- Energy and Power
- Food and Beverages
- Machinery and Equipment
- Manufacturing and Construction
- Medical Devices
- Pharmaceuticals and Healthcare
- Service and Software
- Technology, Media and Telecommunications
- Travel and Tourism
